ROTH Capital Partners to Host Inaugural Healthcare Opportunities Conference on October 6th at the Yale Club in New York City Oct 4, 2022 09:35AM
Adaptimmune Therapeutics plc Announces Closing of Public Offering of American Depositary Shares Jun 4, 2020 10:45AM
Adaptimmune Therapeutics (ADAP) Prices 20.5M ADS Offering at $11/ADS Jun 2, 2020 05:52AM
Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares Jun 1, 2020 09:38PM
Adaptimmune Therapeutics (ADAP) Announces Proposed 12.5M ADS Offering Jun 1, 2020 06:12AM


Jun 1, 2020 06:00AM Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
Feb 7, 2020 04:05PM Adaptimmune Therapeutics plc Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional American Depositary Shares
Jan 24, 2020 04:30PM Adaptimmune Therapeutics plc Announces Closing of Public Offering of American Depositary Shares
Jan 22, 2020 08:49AM Adaptimmune Therapeutics (ADAP) Prices 21 Million Offering at $4/ADS
Jan 22, 2020 08:48AM Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares
May 31, 2019 08:23AM Roth Capital Starts Adaptimmune Therapeutics plc (ADAP) at Buy